19 Jul

BioLife Solutions CryoStor® Cell Freeze Media Embedded in Invossa™: First Approved Cell and Gene Therapy for Osteoarthritis

Korean Approval Received by Kolon Life Science, TissueGene’s Exclusive Licensee BioLife Solutions, Inc. (NASDAQ: BLFS), the leading supplier of pre-formulated, clinical grade cell and tissue hypothermic storage and cryopreservation freeze media (“BioLife”), announced on July 13th 2017 that Kolon Life Science, TissueGene’s exclusive licensee for Asia, including Korea, has received marketing approval for Invossa-K Inj., the world’s […]

read more »
15 Feb

BioLife Solutions’ Joint Venture Partner SAVSU Technologies Provides Performance Update on evo® Cold Chain 2.0™ System in ImmunoCellular Therapeutics Phase 3 Glioblastoma Cell Therapy Clinical Trial

ImmunoCellular Therapeutics has successfully deployed SAVSU’s evo® Cold Chain 2.0™ software-as-a-service (SaaS) live cell visibility platform to pack, ship, track and monitor apheresis units from point of collection to cell therapy manufacturing sites. Cellular immunotherapy ICT-107 is a patient-specific autologous dendritic cell immunotherapy under evaluation to treat study patients with glioblastoma in Phase 3 clinical […]

read more »
03 Nov

BioLife Solutions to Present at 4th Annual European Advanced Therapies Investor Day

BioLife’s CEO Mike Rice will be presenting at the 4th Annual European Advanced Therapies Day on November 3rd at 30 Euston Square, London, England. This one-day, invitation-only meeting provides institutional, corporate and private investors with unique insight into the investment hypothesis for advanced therapies-based treatments and tools. The program includes talks by large pharmaceutical and enabling […]

read more »
18 Apr

Ambient Temp Is Not True Payload Temp!

Sensor based logistics for temperature-sensitive shipments can provide meaningful and actionable data, IF you are measuring the right stuff. Toss in the box GPS-based sensors purport to monitor payload temperature, but significant gradients can exist between the biologic payload temperature and the interior of the shipping container. In the tightly regulated 2-8°C environment, an excursion of a degree or two above or below this range might mean the difference between cells arriving alive and functional vs. dying or dead. Your patients deserve better!

read more »
04 Apr

BioLife Solutions to Showcase the evo™ line of SMART Shippers at this year’s Global Clinical Supplies Group Show!

The Global Clinical Supplies Group conference provides a forum for the open exchange of ideas, regulatory changes, technological advances, and non-confidential information related to clinical supply activities. This conference strives to promote closer professional relationships among personnel engaged in clinical supply activities as well as to encourage stronger connections between the clinical supply group and […]

read more »
22 Feb

Pharma Industry Blindsided By October 1, 2015 Deadline for New EU Requirements On Transportation Qualification And Validation

Having recently chaired the 13th Annual IQPC Cold Chain GDP & Temperature Management Logistics Global Forum in Boston, I’d like to make a few comments regarding the keynote address: “New Challenges in the European Union GMP Guide,” presented by Michael Zwitkovits, GDP & GMP Inspector for the Austrian Federal Office for Safety in Healthcare. It […]

read more »
09 Nov

ISCT Webinar | Optimizing Cold Chain Logistics and Costs: Tips for Product Planning, Storage and Distribution

Sponsored by BioLife Solutions Organized by the ISCT Business Models and Cost of Goods Committee Event Date: Wednesday, November 18, 2015 9am-10am Pacific; 12pm-1pm Eastern; 6pm-7pm CET (Europe) Chair: John Fink, MBA, Product Marketing Manager, Brooks Life Science Systems, USA Speakers: Brian Murphy, PhD, Director, Bioprocess Development, Celgene, USA ​Ian Pope, PhD, MBA, Senior Director, […]

read more »